160 related articles for article (PubMed ID: 26519003)
1. HDL-A molecule with a multi-faceted role in coronary artery disease.
Arora S; Patra SK; Saini R
Clin Chim Acta; 2016 Jan; 452():66-81. PubMed ID: 26519003
[TBL] [Abstract][Full Text] [Related]
2. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
4. The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.
Namiri-Kalantari R; Gao F; Chattopadhyay A; Wheeler AA; Navab KD; Farias-Eisner R; Reddy ST
Biofactors; 2015 May; 41(3):153-9. PubMed ID: 26072738
[TBL] [Abstract][Full Text] [Related]
5. [Molecular Mechanism and Evaluation Method for Anti-Inflammatory HDL].
Tanaka N; Ishida T
Rinsho Byori; 2016 Jan; 64(1):49-56. PubMed ID: 27192797
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis.
Meurs I; Van Eck M; Van Berkel TJ
Curr Pharm Des; 2010 May; 16(13):1445-67. PubMed ID: 20199377
[TBL] [Abstract][Full Text] [Related]
7. Targeting high-density lipoproteins: update on a promising therapy.
Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
[TBL] [Abstract][Full Text] [Related]
8. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
Ayaori M
Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
[TBL] [Abstract][Full Text] [Related]
10. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
11. Atheroprotective effects of high-density lipoproteins.
Assmann G; Nofer JR
Annu Rev Med; 2003; 54():321-41. PubMed ID: 12414916
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein functionality in coronary artery disease.
Kosmas CE; Christodoulidis G; Cheng JW; Vittorio TJ; Lerakis S
Am J Med Sci; 2014 Jun; 347(6):504-8. PubMed ID: 24603157
[TBL] [Abstract][Full Text] [Related]
13. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
14. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
Kratzer A; Giral H; Landmesser U
Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Tuteja S; Rader DJ
Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
[TBL] [Abstract][Full Text] [Related]
19. High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings on reverse cholesterol transport.
Levinson SS
Ann Clin Lab Sci; 2002; 32(2):123-36. PubMed ID: 12017193
[TBL] [Abstract][Full Text] [Related]
20. Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.
Martinez LO; Najib S; Perret B; Cabou C; Lichtenstein L
Atherosclerosis; 2015 Jan; 238(1):89-100. PubMed ID: 25437896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
